Claritas Pharmaceuticals, Inc.

CLAZF · OTC
Analyze with AI
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Assets
Cash & Equivalents$5$32$227$3,686
Short-Term Investments$0$0$0$0
Receivables$206$121$520$113
Inventory$0-$0-$1-$0
Other Curr. Assets$764$0$0$0
Total Curr. Assets$975$153$747$3,799
Property Plant & Equip (Net)$0$0$0$0
Goodwill$1,770$4,692$9,465$11,496
Intangibles$7,694$20,402$49,398$49,981
Long-Term Investments$6$8$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0-$0
Total NC Assets$9,470$25,102$58,863$61,477
Other Assets$0$0$0$0
Total Assets$10,445$25,255$59,610$65,276
Liabilities
Payables$908$1,564$1,656$582
Short-Term Debt$925$363$246$0
Tax Payable$0$0$0$0
Deferred Revenue-$908-$1,564-$1,656$0
Other Curr. Liab.$5,295$3,835$5,918$3,426
Total Curr. Liab.$7,128$5,762$7,820$4,008
LT Debt$0$373$0$2,868
Deferred Rev, NC$0$2,767$0$17,440
Deferred Tax Liab, NC$1,770$6,654$11,276$11,496
Other NC Liab.$40$13,136$30,750$52,593
Total NC Liab.$1,810$22,930$42,026$72,901
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$8,938$28,692$49,846$76,909
Equity
Pref Stock$0$0$0$0
Common Stock$56,514$55,780$43,851$29,369
Retained Earnings-$55,007-$59,217-$38,005-$44,940
AOCI$56,514$55,780$47,769$33,307
Other Equity$0$55,780-$43,851$3,938
Total Equity$1,507-$3,437$9,764-$11,633
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,445$25,255$59,610$65,276
Net Debt$920$704$19-$818